Package Leaflet: Information for the User
Rivaroxaban Bluefish10 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
This medication contains the active substance rivaroxaban and is used in adults to:
This medication belongs to a group of medications called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Bluefish
Do not take Rivaroxaban Bluefish and inform your doctorif any of these circumstances apply to you.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take this medication.
Be careful with Rivaroxaban Bluefish
Inform your doctor if you have any of these situationsbefore taking this medication. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery
Children and Adolescents
This medication is not recommended for children under 18 years of age.There is not enough information about its use in children and adolescents.
Other Medications and Rivaroxaban Bluefish
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those purchased without a prescription.
If any of the above circumstances apply to you, inform your doctorbefore taking this medication, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they will recommend that you also use an ulcer prevention treatment.
If any of the above circumstances apply to you, inform your doctorbefore taking this medication, as the effect of rivaroxaban may be decreased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
Pregnancy and Breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medication, inform your doctor immediately, who will decide how you should be treated.
Driving and Using Machines
This medication may cause dizziness (a common side effect) or fainting (an uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
This medication contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow the instructions for taking this medication exactly as indicated by your doctor. If you are in doubt, consult your doctor or pharmacist again.
What dose to take
The recommended dose is one 10 mg rivaroxaban tablet once a day.
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg tablet once a day or one 20 mg tablet once a day. Your doctor has prescribed rivaroxaban 10 mg once a day for you.
Swallow the tablet, preferably with water.
Rivaroxaban can be taken with or without food.
If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
When to take Rivaroxaban Bluefish
Take one tablet every day, until your doctor tells you to stop.
Try to take one tablet at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first tablet 6 to 10 hours after surgery.
If you have undergone major hip surgery, you will usually take tablets for 5 weeks.
If you have undergone major knee surgery, you will usually take tablets for 2 weeks.
If you take more Rivaroxaban Bluefish than you should
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Rivaroxaban Bluefish
If you forget to take a dose, take it as soon as you remember. Take the next tablet the next day and, after that, take one tablet every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you stop taking Rivaroxaban Bluefish
Do not stop taking rivaroxaban without talking to your doctor first, as rivaroxaban prevents the development of a serious condition.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, rivaroxaban can cause side effects, although not everyone will experience them.
Like other similar medications to reduce blood clotting, rivaroxaban can cause bleeding, which can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be visible.
Tell your doctor immediately if you experience any of the following side effects:
Your doctor will decide to keep you under closer observation or modify your treatment.
The frequency of these side effects is very rare (affecting up to 1 in 10,000 people).
The frequency of severe allergic reactions is very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very Rare(may affect up to 1 in 10,000 people)
Frequency Not Known(cannot be estimated from available data)
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister or bottle, after "CAD" or "EXP". The expiry date is the last day of the month shown.
This medicine does not require any special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple sauce for up to 4 hours.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Rivaroxaban Bluefish
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose, sodium laurilsulfate, magnesium stearate.
Tablet film coating: hypromellose, titanium dioxide (E 171), red iron oxide (E 172).
Appearance and package contents
Rivaroxaban 10 mg film-coated tablets are biconvex, round, pale red tablets with a diameter of approximately 6 mm.
The tablets are packaged in PVC/PVdC//Al blisters.
Package sizes: 10, 14, 28, 30, 98 and 100 tablets.
Not all package sizes may be marketed.
Marketing authorisation holder
Bluefish Pharmaceuticals AB
P.O. Box 49013
100 28 Stockholm
Sweden
Manufacturer
Sofarimex-Indústria Química e Farmacêutica, S.A.
Avenida das Indústrias, Alto de Colaride,
2735-213 Cacém, Portugal.
For further information about this medicine, please contact the local representative of the marketing authorisation holder:
Bluefish Pharma S.L.U.,
AP 36007, 2832094 Madrid,
Sucursal 36
This medicine is authorised in other EEA countries under the following names
Germany | Rivaroxaban Bluefish 10 mg Filmtabletten |
Austria | Rivaroxaban Bluefish 10 mg Filmtabletten |
Denmark | Rivaroxaban Bluefish 10 mg filmovertrukne tabletter |
Spain | Rivaroxabán Bluefish 10 mg comprimidos recubiertos con película EFG |
France | Rivaroxaban Bluefish 10 mg comprimés pelliculés |
Ireland | Rivaroxaban Bluefish 10 mg film-coated tablets |
Iceland | Rivaroxaban Bluefish 10 mg filmuhúðaðar töflur |
Norway | Rivaroxaban Bluefish 10 mg tabletter, filmdrasjerte |
Poland | Rivaroxaban Bluefish |
Portugal | Rivaroxaban Bluefish |
United Kingdom (NI) | Rivaroxaban Bluefish 10 mg film-coated tablets |
Sweden | Rivaroxaban Bluefish |
Date of last revision of this leaflet:January 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es